Breaking Down Block (SQ) Stock Before Q3 Earnings

[ad_1]

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: 

STAAR Surgical STAA: This company which has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma, has seen the Zacks Consensus Estimate for its current year earnings increasing 14.8% over the last 60 days.

STAAR Surgical Company Price and Consensus

STAAR Surgical Company price-consensus-chart | STAAR Surgical Company Quote

Casey’s General Stores CASY: This convenience stores which offer a variety of food selection in 16 Midwestern states, has seen the Zacks Consensus Estimate for its current year earnings increasing 4.9% over the last 60 day.

Casey’s General Stores, Inc. Price and Consensus

Casey's General Stores, Inc. Price and Consensus

Casey’s General Stores, Inc. price-consensus-chart | Casey’s General Stores, Inc. Quote

Gentherm THRM: This company which develops and markets innovative thermal management technologies for a broad range of heating and cooling and temperature control applications, has seen the Zacks Consensus Estimate for its current year earnings increasing 3.0% over the last 60 days.

Gentherm Inc Price and Consensus

Gentherm Inc Price and Consensus

Gentherm Inc price-consensus-chart | Gentherm Inc Quote

MP Materials MP: This company which is the producer of rare earth materials principally in the Western Hemisphere, has seen the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.

MP Materials Corp. Price and Consensus

MP Materials Corp. Price and Consensus

MP Materials Corp. price-consensus-chart | MP Materials Corp. Quote

United Therapeutics UTHR: This biotechnology company which is engaged in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally, has seen the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.

United Therapeutics Corporation Price and Consensus

United Therapeutics Corporation Price and Consensus

United Therapeutics Corporation price-consensus-chart | United Therapeutics Corporation Quote

 

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

United Therapeutics Corporation (UTHR) : Free Stock Analysis Report

Casey’s General Stores, Inc. (CASY) : Free Stock Analysis Report

Gentherm Inc (THRM) : Free Stock Analysis Report

STAAR Surgical Company (STAA) : Free Stock Analysis Report

MP Materials Corp. (MP) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

[ad_2]

Image and article originally from www.nasdaq.com. Read the original article here.

By Zacks